Challenges of Diabetes Care in Older People With Type 2 Diabetes and the Role of Basal Insulin
Open Access
- 1 October 2019
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 37 (4), 357-367
- https://doi.org/10.2337/cd18-0074
Abstract
IN BRIEF The use of long-acting basal insulin analogs is a recommended strategy in older people with diabetes because of their lower risk of hypoglycemia compared to intermediate-acting insulins. In this article, we review the results from recent clinical trials of second-generation basal insulin preparations. We conclude that, although these preparations have improved the management of insulin-requiring older people with type 2 diabetes, there is a need for additional and more specific studies to address the complexities of hyperglycemia management in this population.Keywords
This publication has 45 references indexed in Scilit:
- Elderly Patients with Diabetes Experience a Lower Rate of Nocturnal Hypoglycaemia with Insulin Degludec than with Insulin Glargine: A Meta-Analysis of Phase IIIa TrialsDrugs & Aging, 2013
- Safety and Effectiveness of Insulin Detemir in Different Age-Groups in the A1chieve StudyDiabetes Therapy, 2013
- Observational Study of Once-Daily Insulin Detemir in People with Type 2 Diabetes Aged 75 Years or OlderDrugs & Aging, 2013
- Diabetes in Older Adults: A Consensus ReportJournal of the American Geriatrics Society, 2012
- Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled AnalysisJournal of the American Geriatrics Society, 2012
- European Diabetes Working Party for Older People 2011 Clinical Guidelines for Type 2 Diabetes Mellitus. Executive SummaryDiabetes & Metabolism, 2011
- Insulin detemir versus insulin glargine for type 2 diabetes mellitusEmergencias, 2011
- Elimination of Hypoglycemia From the Lives of People Affected by DiabetesDiabetes, 2011
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesDiabetologia, 2008